President Donald Trump announced a new round of import tariffs that will take effect on Oct. 1, 2025, led by a 100% tariff on branded and patented pharmaceutical products.
The package also includes a 50% tariff on kitchen cabinets, bathroom vanities and related items, a 30% tariff on upholstered furniture, and a 25% tariff on heavy trucks built outside the United States.
In posts on his Truth Social account, Trump framed the action as a supply chain strategy to reduce reliance on foreign producers and strengthen domestic manufacturing.
What the tariff package includes
According to the announcement, the 100% tariff will apply to imported brand-name or patented drugs unless the manufacturer is actively building a plant in the United States.
The administration described this exemption as a way to accelerate onshoring in a sector it views as critical to national resilience. The tariff list further targets home goods and heavy trucks, sectors the White House has linked to industrial capacity and national security.
The duties on consumer home products are structured at 50% for kitchen cabinets, bathroom vanities and similar categories, and 30% for upholstered furniture. For transportation equipment, a 25% tariff will apply to heavy trucks assembled abroad.
The administration said these measures are aimed at curbing what it described as import “flooding” that has pressured U.S. manufacturers.
Administration’s case for action
Peter Navarro, senior counselor for trade and manufacturing, said the goal is to shift production back to the United States and limit leverage that foreign suppliers could exert over essential goods. Speaking on Fox Business’ “Mornings with Maria,” Navarro cited a case involving an antibiotic, where a Chinese company received an FDA approval, then financed an Indian company that won a Department of Veterans Affairs contract, displacing an American producer.
He argued that similar dynamics have occurred across sectors, which in his view justifies the tariff approach.
Navarro added that critical medicines and active pharmaceutical ingredients should not be subject to foreign pressure. “We cannot be caught with our antibiotics down and other pharmaceuticals,” he said. He also reiterated the administration’s position that there would be no tariffs for companies building production inside the United States, presenting the policy as an explicit incentive to invest domestically.
Pharmaceuticals, pricing, and supply chains
The drug provision focuses on branded and patented medicines, with a carveout for firms that are building U.S. facilities. Companies will look for clarity on how “actively building” is defined, since drug manufacturing plants can take years to plan and construct.
The administration’s messaging indicates that breaking ground or having an ongoing build would satisfy the condition, but further agency guidance would determine how exemptions are verified.
Navarro also pointed to long-running pricing disparities between the U.S. market and other countries, describing what he called cross-subsidies where American consumers pay more for the same products sold for less abroad. He said the administration is pressing on multiple fronts to address those differences while pushing for domestic capacity in medical supply chains.
Details on how those fronts interact with the new tariffs were not provided in the announcement.
Home goods and heavy trucks
The tariff plan extends to household products and furniture, areas U.S. manufacturers say have faced intense import competition.
Real-estate executive Isaac Toledano, founder and CEO of BH Group, told Fox News Digital that a 50% duty on cabinets and vanities could create short-term pricing and supply disruptions, but might also open opportunities for domestic production in regions like South Florida. He said a shift toward local sourcing could support growth and job creation, though consumers may feel initial price pressure.
On heavy trucks, Navarro described the sector as strategically important. He said the ability to convert commercial capacity for national needs during a conflict is a consideration, which is why retaining industrial capability inside the United States is part of the policy rationale.
The 25% tariff is intended to nudge assembly and component sourcing toward domestic plants rather than offshore facilities.
